α-tocopherol and β-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: Effects of base- line characteristics and study compliance

Journal of the National Cancer Institute

Volumn 88, Issue 21, 1996, Pages 1560-1570

  Albanes, Demetrius ^a,i   Heinonen, Olli P ^b   Taylor, Philip R ^a   Virtamo, Jarmo ^c   Edwards, Brenda K ^a   Rautalahti, Matti ^c   Hartman, Anne M ^a   Palmgren, Juni ^c   Freedman, Laurence S ^a   Haapakoski, Jaason ^c   Barrett, Michael J ^d   Pietinen, Pirjo ^c   Malila, Nea ^c   Tala, Eero ^e   Liippo, Kari ^e   Salomaa, Eija Riitta ^e   Tangrea, Joseph A ^a   Teppo, Lyly ^f   Askin, Frederic B ^g   Taskinen, Eero ^h   Erozan, Yener ^g   Greenwald, Peter ^a   Huttunen, Jussi K ^c   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d INFORMATION MANAGEMENT SERVICES INC   (United States)

^e TURKU UNIVERSITY HOSPITAL   (Finland)

^f FINNISH CANCER REGISTRY   (Finland)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF HELSINKI   (Finland)

ⁱ NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER SURVIVAL; CIGARETTE SMOKING; CLINICAL TRIAL; DIET SUPPLEMENTATION; FOLLOW UP; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT;

AGE FACTORS; AGED; ALCOHOL DRINKING; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; BETA CAROTENE; CARCINOGENS; FOOD, FORTIFIED; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PROPORTIONAL HAZARDS MODELS; RISK; RISK FACTORS; SMOKING; VITAMIN E;

EID: 10344238570     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.21.1560     Document Type: Article

References (37)

1. The ATBC Cancer Prevention Study Group. The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study (ATBC Study): design, methods, participant characteristics, and compliance [see comment citation in Medline]. Ann Epidemiol 1994;4:1-10.
2. The ATBC Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers [see comment citation in Medline]. N Engl J Med 1994;330:1029-35.
3. Albanes D, Heinonen OP, Huttunen JK, Taylor PR, Virtamo J, Edwards BK, et al. Effects of α-tocopherol and β-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Clin Nutr 1995;62(6 Suppl):1427S-1430S.
4. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease [see comment citation in Medline]. N Engl J Med 1996;334:1150-5.
5. Ziegler RG. A review of epidemiologic evidence that carotenoids reduce the risk of cancer. J Nutr 1989;119:116-22.
6. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Control 1991;2:325-57.
7. Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 1992;18:1-29.
8. Bendich A, Olson JA. Biological actions of carotenoids. FASEB J 1989;3:1927-32.
9. Krinsky NI. Carotenoids and cancer in animal models. J Nutr 1989; 119:123-6.
10. Pietinen P, Hartman AM, Haapa E, Rasanen L, Haapakoski J, Palmgren J, et al. Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol 1988;128:655-66.
11. Milne DB, Botnen J. Retinol, alpha-tocopherol, lycopene, and alpha- and beta-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem 1986;32:874-6.
12. American Joint Committee on Cancer (AJCC). Lung. In: Beahrs OH, Hensen DE, Hutter RV, Myers MH, editors. Manual for staging of cancer, 4th ed. Philadelphia: Lippincott, 1992:115-22.
13. Percy C, Van Holten V, Muir C. International Classification of Diseases for Oncology, 2nd ed. Geneva: World Health Organization, 1990.
14. US Department of Health and Human Services. International Classification of Diseases, 9th Revision, Clinical Modification. 4th ed. Washington (DC): US Public Health Service, 1991.
15. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: Wiley, 1980.
16. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease [see comment citation in Medline]. N Engl J Med 1996;334:1145-9.
17. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population [see comment citations in Medline]. J Natl Cancer Inst 1993;85:1483-92.
18. Blot WJ, Li JY, Taylor PR, Li B. Lung cancer and vitamin supplementation [letter]. N Engl J Med 1994;331:614.
19. Li JY, Taylor PR, Li B, Dawsey S, Wang GQ, Ershow AG, et al. Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia [see comment citation in Medline]. J Natl Cancer Inst 1993;85:1492-8.
20. Greenberg ER, Baron JA, Stukel TA, Stevens MM, Mandel JS, Spencer SK, et al. A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group [published erratum appears in N Engl J Med 1991;325:1324] [see comment citations in Medline]. N Engl J Med 1990;323:789-95.
21. Greenberg ER, Baron JA, Tosteson TD, Freeman DH Jr, Beck GJ, Bond JH, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. The Polyp Prevention Study Group [see comment citations in Medline]. N Engl J Med 1994;331:141-7.
22. MacLennan R, Macrae F, Bain C, Battistutta D, Chapuis P, Gratten H, et al. Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. The Australian Polyp Prevention Project [see comment citations in Medline]. J Natl Cancer Inst 1995;87:1760-6.
23. Greenberg ER, Baron JA, Karagas MR, Stukel TA, Nierenberg DW, Stevens MM, et al. Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. JAMA 1996;275:699-703.
24. McLarty JW, Holiday DB, Girard WM, Yanagihara RH, Kummet TD, Greenberg SD. β-Carotene, vitamin A, and lung cancer chemoprevention: results of an intermediate endpoint study. Am J Clin Nutr 1995;62(6 Suppl):1431S-1438S.
25. Burton GW, Ingold KU. β-Carotene: an unusual type of lipid antioxidant. Science 1984;224:569-73.
26. Wahlqvist ML, Wattanapenpaiboon N, Macrae FA, Lambert JR, Mac-Lennan R, Hsu-Hage B. Changes in serum carotenoids in subjects with colorectal adenomas after 24 mo of beta-carotene supplementation. Australian Polyp Prevention Project Investigators. Am J Clin Nutr 1994; 60:936-43.
27. White WS, Stacewicz-Sapuntzakis M, Erdman JW Jr. Bowen PE. Pharmacokinetics of β-carotene and canthaxanthin after ingestion of individual and combined doses by human subjects. J Am Coll Nutr 1994;13:665-71.
28. Kostic D, White WS, Olson JA. Intestinal absorption, serum clearance, and interactions between lutein and β-carotene when administered to human adults in separate or combined oral doses. Am J Clin Nutr 1995;62:604-10.
29. Mayne ST, Graham S, Zheng TZ. Dietary retinol: prevention or promotion of carcinogenesis in humans? [published erratum appears in Cancer Causes Control 1992;3:184]. Cancer Causes Control 1991;2:443-50.
30. Ahmed S, Leo MA, Lieber CS. Interactions between alcohol and β-carotene in patients with alcoholic liver disease. Am J Clin Nutr 1994; 60:430-6.
31. Lecomte E, Herbeth B, Pirollet P, Chancerelle Y, Arnaud J, Musse N, et al. Effect of alcohol consumption on blood antioxidant nutrients and oxidative stress indicators. Am J Clin Nutr 1994;60:255-61.
32. Leo MA, Kim C, Lowe N, Lieber CS. Interaction of ethanol with β-carotene: delayed blood clearance and enhanced hepatotoxicity. Hepatology 1992;15:883-91.
33. Mathews-Roth MM. Anti-tumor activity of β-carotene, canthaxanthin and phytoene. Oncology 1982;39:33-7
34. Chen LC, Sly L, Jones CS, Tarone R, De Luca LM. Differential effects of dietary β-carotene on papilloma and carcinoma formation induced by an initiation-promotion protocol in SENCAR mouse skin. Carcinogenesis 1993;14:713-7.
35. Wolterbeek AP, Schoevers EJ, Bruyntjes JP, Rutten AA, Feron VJ. Benzo[a]pyrene-induced respiratory tract cancer in hamsters fed a diet rich in β-carotene. A histomorphological study. J Environ Pathol Toxicol Oncol 1995;14:35-43.
36. Le Marchand L, Hankin JH, Kolonel LN, Beecher GR, Wilkens LR, Zhao LP. Intake of specific carotenoids and lung cancer risk [published erratum appears in Cancer Epidemiol Biomarkers Prev 1994;3:523]. Cancer Epidemiol Biomarkers Prev 1993;2:183-7.
37. Ziegler RG, Colavito EA, Hartge P, McAdams MJ, Schoenberg JB, Mason TJ, et al. Importance of α-carotene, β-carotene. and other phytochemicals in the etiology of lung cancer. J Natl Cancer Inst 1996;88:612-5.